|
1
|
Body-mass index and mortality among 1.46 million white adults.
|
N Engl J Med
|
2010
|
13.34
|
|
2
|
Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.
|
JAMA
|
2011
|
9.13
|
|
3
|
Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001.
|
Blood
|
2005
|
8.37
|
|
4
|
50-year trends in smoking-related mortality in the United States.
|
N Engl J Med
|
2013
|
7.80
|
|
5
|
Reporting participation in epidemiologic studies: a survey of practice.
|
Am J Epidemiol
|
2005
|
6.52
|
|
6
|
Epidemiologic evaluation of measurement data in the presence of detection limits.
|
Environ Health Perspect
|
2004
|
6.43
|
|
7
|
Performance of common genetic variants in breast-cancer risk models.
|
N Engl J Med
|
2010
|
5.79
|
|
8
|
Smoking and mortality--beyond established causes.
|
N Engl J Med
|
2015
|
5.54
|
|
9
|
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer.
|
Nat Genet
|
2009
|
5.14
|
|
10
|
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33.
|
Nat Genet
|
2010
|
4.89
|
|
11
|
ABO blood group and the risk of pancreatic cancer.
|
J Natl Cancer Inst
|
2009
|
4.72
|
|
12
|
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents.
|
Lancet
|
2016
|
4.49
|
|
13
|
Menopausal hormone replacement therapy and risk of ovarian cancer.
|
JAMA
|
2002
|
4.39
|
|
14
|
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium.
|
Lancet Oncol
|
2006
|
4.13
|
|
15
|
Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer.
|
JAMA
|
2012
|
3.85
|
|
16
|
Cancer risk prediction models: a workshop on development, evaluation, and application.
|
J Natl Cancer Inst
|
2005
|
3.75
|
|
17
|
Detectable clonal mosaicism and its relationship to aging and cancer.
|
Nat Genet
|
2012
|
3.69
|
|
18
|
Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens.
|
Cancer Prev Res (Phila)
|
2011
|
3.33
|
|
19
|
Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial.
|
Am J Obstet Gynecol
|
2005
|
3.25
|
|
20
|
A road map for efficient and reliable human genome epidemiology.
|
Nat Genet
|
2006
|
3.21
|
|
21
|
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer.
|
Cancer Prev Res (Phila)
|
2011
|
3.03
|
|
22
|
Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium.
|
Am J Epidemiol
|
2010
|
2.86
|
|
23
|
Transforming epidemiology for 21st century medicine and public health.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
2.56
|
|
24
|
Etiologic heterogeneity among non-Hodgkin lymphoma subtypes.
|
Blood
|
2008
|
2.49
|
|
25
|
Positional accuracy of two methods of geocoding.
|
Epidemiology
|
2005
|
2.47
|
|
26
|
Leisure time physical activity of moderate to vigorous intensity and mortality: a large pooled cohort analysis.
|
PLoS Med
|
2012
|
2.45
|
|
27
|
Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32.
|
Nat Genet
|
2010
|
2.37
|
|
28
|
Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007.
|
JAMA
|
2011
|
2.31
|
|
29
|
Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis.
|
Lancet Oncol
|
2005
|
2.27
|
|
30
|
Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers.
|
Cancer Epidemiol Biomarkers Prev
|
2004
|
2.19
|
|
31
|
Adverse health outcomes in women exposed in utero to diethylstilbestrol.
|
N Engl J Med
|
2011
|
2.16
|
|
32
|
Consumption of aspartame-containing beverages and incidence of hematopoietic and brain malignancies.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
2.15
|
|
33
|
Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph).
|
Blood
|
2006
|
2.15
|
|
34
|
Projecting the performance of risk prediction based on polygenic analyses of genome-wide association studies.
|
Nat Genet
|
2013
|
2.09
|
|
35
|
Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma.
|
Cancer Res
|
2006
|
2.06
|
|
36
|
Identifying individuals at high risk of melanoma: a practical predictor of absolute risk.
|
J Clin Oncol
|
2006
|
2.05
|
|
37
|
Diet and melanoma in a case-control study.
|
Cancer Epidemiol Biomarkers Prev
|
2004
|
2.05
|
|
38
|
Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study.
|
J Natl Cancer Inst
|
2003
|
2.04
|
|
39
|
Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium.
|
Int J Cancer
|
2008
|
2.02
|
|
40
|
Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes.
|
Blood
|
2006
|
2.02
|
|
41
|
Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium.
|
Int J Cancer
|
2008
|
2.01
|
|
42
|
Genome-wide association study of glioma and meta-analysis.
|
Hum Genet
|
2012
|
1.96
|
|
43
|
Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.
|
Am J Epidemiol
|
2010
|
1.95
|
|
44
|
Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma.
|
Carcinogenesis
|
2007
|
1.94
|
|
45
|
Proximity to crops and residential exposure to agricultural herbicides in iowa.
|
Environ Health Perspect
|
2006
|
1.92
|
|
46
|
Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium.
|
Clin Gastroenterol Hepatol
|
2008
|
1.91
|
|
47
|
Correlates of circulating 25-hydroxyvitamin D: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.
|
Am J Epidemiol
|
2010
|
1.90
|
|
48
|
Organochlorines in carpet dust and non-Hodgkin lymphoma.
|
Epidemiology
|
2005
|
1.89
|
|
49
|
Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan).
|
Arch Intern Med
|
2010
|
1.88
|
|
50
|
Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium.
|
Am J Epidemiol
|
2009
|
1.87
|
|
51
|
Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph).
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
1.87
|
|
52
|
Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.
|
Nat Genet
|
2013
|
1.85
|
|
53
|
Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium.
|
Cancer Res
|
2010
|
1.82
|
|
54
|
Cigarette smoking and cancer risk: modeling total exposure and intensity.
|
Am J Epidemiol
|
2007
|
1.80
|
|
55
|
Comparison of pesticide levels in carpet dust and self-reported pest treatment practices in four US sites.
|
J Expo Anal Environ Epidemiol
|
2004
|
1.76
|
|
56
|
Genetic variation and willingness to participate in epidemiologic research: data from three studies.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
1.66
|
|
57
|
Genome-wide association study of survival in patients with pancreatic adenocarcinoma.
|
Gut
|
2012
|
1.66
|
|
58
|
Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival.
|
Blood
|
2007
|
1.63
|
|
59
|
GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma.
|
PLoS Genet
|
2011
|
1.58
|
|
60
|
Menstrual and reproductive characteristics of women whose mothers were exposed in utero to diethylstilbestrol (DES).
|
Int J Epidemiol
|
2006
|
1.57
|
|
61
|
A subset-based approach improves power and interpretation for the combined analysis of genetic association studies of heterogeneous traits.
|
Am J Hum Genet
|
2012
|
1.57
|
|
62
|
Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology.
|
Blood
|
2010
|
1.56
|
|
63
|
Persistent organochlorine chemicals in plasma and risk of non-Hodgkin's lymphoma.
|
Cancer Res
|
2005
|
1.55
|
|
64
|
Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk.
|
PLoS One
|
2009
|
1.52
|
|
65
|
Circulating 25-hydroxyvitamin D and risk of non-hodgkin lymphoma: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.
|
Am J Epidemiol
|
2010
|
1.52
|
|
66
|
A network of investigator networks in human genome epidemiology.
|
Am J Epidemiol
|
2005
|
1.43
|
|
67
|
Average midrange ultraviolet radiation flux and time outdoors predict melanoma risk.
|
Cancer Res
|
2002
|
1.42
|
|
68
|
Potential role of HE4 in multimodal screening for epithelial ovarian cancer.
|
J Natl Cancer Inst
|
2011
|
1.39
|
|
69
|
Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
1.39
|
|
70
|
Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: a case-control study.
|
Am J Epidemiol
|
2005
|
1.36
|
|
71
|
Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.
|
J Natl Cancer Inst
|
2006
|
1.35
|
|
72
|
Genetics of reproductive lifespan.
|
Nat Genet
|
2009
|
1.34
|
|
73
|
An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population.
|
PLoS One
|
2013
|
1.33
|
|
74
|
Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case-control study.
|
Int J Cancer
|
2004
|
1.32
|
|
75
|
Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study.
|
Blood
|
2007
|
1.30
|
|
76
|
Ovarian cancer risk factors by histologic subtypes in the NIH-AARP Diet and Health Study.
|
Int J Cancer
|
2011
|
1.30
|
|
77
|
The epidemic of non-Hodgkin lymphoma in the United States: disentangling the effect of HIV, 1992-2009.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
1.27
|
|
78
|
A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers.
|
Int J Cancer
|
2009
|
1.26
|
|
79
|
Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era.
|
Blood
|
2008
|
1.26
|
|
80
|
Joint effect of genes and environment distorted by selection biases: implications for hospital-based case-control studies.
|
Cancer Epidemiol Biomarkers Prev
|
2002
|
1.25
|
|
81
|
Vitamin D and cancer: current dilemmas and future needs.
|
Nutr Rev
|
2007
|
1.25
|
|
82
|
Personal use of hair dye and the risk of certain subtypes of non-Hodgkin lymphoma.
|
Am J Epidemiol
|
2008
|
1.23
|
|
83
|
Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort.
|
BMC Cancer
|
2009
|
1.22
|
|
84
|
Vegetables, fruit, and antioxidant-related nutrients and risk of non-Hodgkin lymphoma: a National Cancer Institute-Surveillance, Epidemiology, and End Results population-based case-control study.
|
Am J Clin Nutr
|
2006
|
1.22
|
|
85
|
Associations between anthropometry, cigarette smoking, alcohol consumption, and non-Hodgkin lymphoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
|
Am J Epidemiol
|
2010
|
1.21
|
|
86
|
Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts.
|
Cancer Causes Control
|
2010
|
1.21
|
|
87
|
Alcohol, smoking, and body size in relation to incident Hodgkin's and non-Hodgkin's lymphoma risk.
|
Am J Epidemiol
|
2007
|
1.21
|
|
88
|
Risk of breast cancer in women exposed to diethylstilbestrol in utero: prelimiinary results (United States).
|
Cancer Causes Control
|
2002
|
1.20
|
|
89
|
Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer.
|
Carcinogenesis
|
2012
|
1.20
|
|
90
|
Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma.
|
Cancer Causes Control
|
2005
|
1.20
|
|
91
|
Risk of non-Hodgkin lymphoma and nitrate and nitrite from drinking water and diet.
|
Epidemiology
|
2006
|
1.19
|
|
92
|
Psychosexual characteristics of men and women exposed prenatally to diethylstilbestrol.
|
Epidemiology
|
2003
|
1.17
|
|
93
|
Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium.
|
Cancer Causes Control
|
2012
|
1.17
|
|
94
|
Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
1.17
|
|
95
|
Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors.
|
Cancer Res
|
2007
|
1.17
|
|
96
|
Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma.
|
Carcinogenesis
|
2006
|
1.16
|
|
97
|
Meat and meat-mutagen intake and risk of non-Hodgkin lymphoma: results from a NCI-SEER case-control study.
|
Carcinogenesis
|
2005
|
1.14
|
|
98
|
Medication use and risk of ovarian carcinoma: a prospective study.
|
Int J Cancer
|
2004
|
1.13
|
|
99
|
Adjustment for competing risk in kin-cohort estimation.
|
Genet Epidemiol
|
2003
|
1.13
|
|
100
|
Key elements of access policies for biorepositories associated with population science research.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
1.12
|
|
101
|
Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma.
|
Pharmacogenet Genomics
|
2006
|
1.12
|
|
102
|
Smoking, alcohol use, obesity, and overall survival from non-Hodgkin lymphoma: a population-based study.
|
Cancer
|
2010
|
1.12
|
|
103
|
Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
1.11
|
|
104
|
Association of energy intake and energy balance with postmenopausal breast cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
1.11
|
|
105
|
Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies.
|
PLoS Med
|
2013
|
1.11
|
|
106
|
A case-control study of occupational exposure to trichloroethylene and non-Hodgkin lymphoma.
|
Environ Health Perspect
|
2011
|
1.10
|
|
107
|
Interleukin-6-related genotypes, body mass index, and risk of multiple myeloma and plasmacytoma.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
1.10
|
|
108
|
A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma.
|
Carcinogenesis
|
2008
|
1.08
|
|
109
|
Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan).
|
Int J Cancer
|
2010
|
1.07
|
|
110
|
Alcohol intake and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium (PanScan).
|
Cancer Causes Control
|
2010
|
1.07
|
|
111
|
Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.
|
Cancer
|
2004
|
1.07
|
|
112
|
Effect of changing breast cancer incidence rates on the calibration of the Gail model.
|
J Clin Oncol
|
2010
|
1.05
|
|
113
|
Residential insecticide use and risk of non-Hodgkin's lymphoma.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
1.05
|
|
114
|
Offspring of women exposed in utero to diethylstilbestrol (DES): a preliminary report of benign and malignant pathology in the third generation.
|
Epidemiology
|
2008
|
1.05
|
|
115
|
Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research.
|
J Natl Cancer Inst
|
2012
|
1.04
|
|
116
|
Sun exposure, vitamin D receptor gene polymorphisms and risk of non-Hodgkin lymphoma.
|
Cancer Causes Control
|
2007
|
1.04
|
|
117
|
Obesity, lifestyle factors, and risk of myelodysplastic syndromes in a large US cohort.
|
Am J Epidemiol
|
2009
|
1.04
|
|
118
|
IARC monographs: 40 years of evaluating carcinogenic hazards to humans.
|
Environ Health Perspect
|
2015
|
1.03
|
|
119
|
Metabolic gene variants and risk of non-Hodgkin's lymphoma.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
1.03
|
|
120
|
Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies.
|
Blood
|
2009
|
1.01
|
|
121
|
Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium.
|
Blood
|
2012
|
1.01
|
|
122
|
Body mass index and risk of death in Asian Americans.
|
Am J Public Health
|
2014
|
1.01
|
|
123
|
Potential excess mortality in BRCA1/2 mutation carriers beyond breast, ovarian, prostate, and pancreatic cancers, and melanoma.
|
PLoS One
|
2009
|
1.01
|
|
124
|
Analysis of Environmental Chemical Mixtures and Non-Hodgkin Lymphoma Risk in the NCI-SEER NHL Study.
|
Environ Health Perspect
|
2015
|
1.00
|
|
125
|
Consortia in cancer epidemiology: lessons from InterLymph.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
1.00
|
|
126
|
Ovarian cancer screening in women with a family history of breast or ovarian cancer.
|
Obstet Gynecol
|
2006
|
0.99
|
|
127
|
Genetic variation in Th1/Th2 pathway genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies.
|
Br J Haematol
|
2011
|
0.98
|
|
128
|
Hormone replacement therapy, reproductive history, and colorectal adenomas: data from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial (United States).
|
Cancer Causes Control
|
2005
|
0.98
|
|
129
|
Environmental determinants of polychlorinated biphenyl concentrations in residential carpet dust.
|
Environ Sci Technol
|
2013
|
0.96
|
|
130
|
Hormone-related risk factors and postmenopausal breast cancer among nulliparous versus parous women: An aggregated study.
|
Am J Epidemiol
|
2011
|
0.96
|
|
131
|
Prevalence, incidence, and natural history of simple ovarian cysts among women >55 years old in a large cancer screening trial.
|
Am J Obstet Gynecol
|
2010
|
0.95
|
|
132
|
The relationship between multiple myeloma and occupational exposure to six chlorinated solvents.
|
Occup Environ Med
|
2010
|
0.95
|
|
133
|
A pooled analysis of bladder cancer case-control studies evaluating smoking in men and women.
|
Cancer Causes Control
|
2006
|
0.94
|
|
134
|
A pooled analysis of three studies evaluating genetic variation in innate immunity genes and non-Hodgkin lymphoma risk.
|
Br J Haematol
|
2011
|
0.93
|
|
135
|
Reproductive risk factors for cutaneous melanoma in women: a case-control study.
|
Am J Epidemiol
|
2006
|
0.93
|
|
136
|
Genome-wide association study of endometrial cancer in E2C2.
|
Hum Genet
|
2013
|
0.93
|
|
137
|
Age at natural menopause in women exposed to diethylstilbestrol in utero.
|
Am J Epidemiol
|
2006
|
0.93
|
|
138
|
Dietary flavonoid intake and non-Hodgkin lymphoma risk.
|
Am J Clin Nutr
|
2008
|
0.93
|
|
139
|
Antibodies to JC and BK viruses among persons with non-Hodgkin lymphoma.
|
Int J Cancer
|
2005
|
0.93
|
|
140
|
Joint associations between genetic variants and reproductive factors in glioma risk among women.
|
Am J Epidemiol
|
2011
|
0.92
|
|
141
|
Organochlorine exposure, immune gene variation, and risk of non-Hodgkin lymphoma.
|
Blood
|
2008
|
0.92
|
|
142
|
Body mass index and physical activity at different ages and risk of multiple myeloma in the NIH-AARP diet and health study.
|
Am J Epidemiol
|
2013
|
0.92
|
|
143
|
Heterogeneity of risk for melanoma and pancreatic and digestive malignancies: a melanoma case-control study.
|
Cancer
|
2004
|
0.92
|
|
144
|
Vegetables- and antioxidant-related nutrients, genetic susceptibility, and non-Hodgkin lymphoma risk.
|
Cancer Causes Control
|
2008
|
0.91
|
|
145
|
Non-steroidal anti-inflammatory drug use and ovarian cancer risk: findings from the NIH-AARP Diet and Health Study and systematic review.
|
Cancer Causes Control
|
2012
|
0.91
|
|
146
|
Personal history of diabetes, genetic susceptibility to diabetes, and risk of brain glioma: a pooled analysis of observational studies.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
0.91
|
|
147
|
Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci.
|
Am J Epidemiol
|
2015
|
0.91
|
|
148
|
Blood transfusion, anesthesia, surgery and risk of non-Hodgkin lymphoma in a population-based case-control study.
|
Int J Cancer
|
2008
|
0.90
|
|
149
|
Relationship between interferon regulatory factor 4 genetic polymorphisms, measures of sun sensitivity and risk for non-Hodgkin lymphoma.
|
Cancer Causes Control
|
2009
|
0.90
|
|
150
|
The association between self-reported diabetes and cancer incidence in the NIH-AARP Diet and Health Study.
|
J Clin Endocrinol Metab
|
2013
|
0.89
|
|
151
|
Power of data mining methods to detect genetic associations and interactions.
|
Hum Hered
|
2011
|
0.89
|
|
152
|
Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma in a pooled analysis of three studies.
|
Br J Haematol
|
2010
|
0.89
|
|
153
|
PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortium.
|
Blood
|
2012
|
0.89
|
|
154
|
An aggregated analysis of hormonal factors and endometrial cancer risk by parity.
|
Cancer
|
2012
|
0.88
|
|
155
|
From epidemiology to policy: toward more effective practice.
|
Ann Epidemiol
|
2010
|
0.88
|
|
156
|
Variations in chromosomes 9 and 6p21.3 with risk of non-Hodgkin lymphoma.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
0.88
|
|
157
|
Known glioma risk loci are associated with glioma with a family history of brain tumours -- a case-control gene association study.
|
Int J Cancer
|
2012
|
0.88
|
|
158
|
Ovarian volume: determinants and associations with cancer among postmenopausal women.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
0.87
|
|
159
|
Risk factors for non-Hodgkin lymphoma subtypes defined by histology and t(14;18) in a population-based case-control study.
|
Int J Cancer
|
2010
|
0.87
|
|
160
|
Finding ovarian cancer.
|
J Natl Cancer Inst
|
2012
|
0.86
|
|
161
|
Association between adult height, genetic susceptibility and risk of glioma.
|
Int J Epidemiol
|
2012
|
0.86
|
|
162
|
Joint effects between five identified risk variants, allergy, and autoimmune conditions on glioma risk.
|
Cancer Causes Control
|
2013
|
0.85
|
|
163
|
Inferring past pesticide exposures: a matrix of individual active ingredients in home and garden pesticides used in past decades.
|
Environ Health Perspect
|
2006
|
0.85
|
|
164
|
Occupation and Risk of Non-Hodgkin Lymphoma and Its Subtypes: A Pooled Analysis from the InterLymph Consortium.
|
Environ Health Perspect
|
2015
|
0.85
|
|
165
|
Smoking-related mortality in the United States.
|
N Engl J Med
|
2013
|
0.85
|
|
166
|
Cyclin D1 splice variant and risk for non-Hodgkin lymphoma.
|
Hum Genet
|
2006
|
0.85
|
|
167
|
Cancer screening: the journey from epidemiology to policy.
|
Ann Epidemiol
|
2012
|
0.85
|
|
168
|
Ovarian volumes among women with endometrial carcinoma: associations with risk factors and serum hormones.
|
Gynecol Oncol
|
2007
|
0.84
|
|
169
|
Genetic variation on 9p22 is associated with abnormal ovarian ultrasound results in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
|
PLoS One
|
2011
|
0.84
|
|
170
|
Body mass index and mortality in non-Hispanic black adults in the NIH-AARP Diet and Health Study.
|
PLoS One
|
2012
|
0.82
|
|
171
|
Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States.
|
J Natl Cancer Inst
|
2004
|
0.82
|
|
172
|
Leveraging family history in population-based case-control association studies.
|
Genet Epidemiol
|
2014
|
0.82
|
|
173
|
Cellular telephones and non-Hodgkin lymphoma.
|
Int J Cancer
|
2006
|
0.81
|
|
174
|
BRCA1 and sex ratio.
|
Eur J Hum Genet
|
2004
|
0.81
|
|
175
|
Genes, hormones, and pathways to breast cancer.
|
N Engl J Med
|
2003
|
0.81
|
|
176
|
Assessing disease risk in genome-wide association studies using family history.
|
Epidemiology
|
2012
|
0.80
|
|
177
|
Variation in effects of non-Hodgkin lymphoma risk factors according to the human leukocyte antigen (HLA)-DRB1*01:01 allele and ancestral haplotype 8.1.
|
PLoS One
|
2011
|
0.80
|
|
178
|
Genetic effects and modifiers of radiotherapy and chemotherapy on survival in pancreatic cancer.
|
Pancreas
|
2011
|
0.80
|
|
179
|
Antibody responses to simian virus 40 T antigen: a case-control study of non-Hodgkin lymphoma.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
0.80
|
|
180
|
Breast cancer risks for BRCA1/2 carriers.
|
Science
|
2004
|
0.80
|
|
181
|
Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemiologic study in the pre-rituximab era.
|
Int J Mol Epidemiol Genet
|
2011
|
0.79
|
|
182
|
Designing early detection programs for ovarian cancer.
|
J Natl Cancer Inst
|
2009
|
0.79
|
|
183
|
Human leukocyte antigen class I and II alleles and overall survival in diffuse large B-cell lymphoma and follicular lymphoma.
|
ScientificWorldJournal
|
2011
|
0.78
|
|
184
|
Polymorphisms in genes related to one-carbon metabolism are not related to pancreatic cancer in PanScan and PanC4.
|
Cancer Causes Control
|
2013
|
0.78
|
|
185
|
Re: Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma, author response.
|
Carcinogenesis
|
2008
|
0.77
|
|
186
|
LIM domain only 2 protein expression, LMO2 germline genetic variation, and overall survival in diffuse large B-cell lymphoma in the pre-rituximab era.
|
Leuk Lymphoma
|
2012
|
0.77
|
|
187
|
Inherited genetic variation and overall survival following follicular lymphoma.
|
Am J Hematol
|
2012
|
0.77
|
|
188
|
Asthma history, occupational exposure to pesticides and the risk of non-Hodgkin's lymphoma.
|
Int J Cancer
|
2006
|
0.77
|
|
189
|
A resequence analysis of genomic loci on chromosomes 1q32.1, 5p15.33, and 13q22.1 associated with pancreatic cancer risk.
|
Pancreas
|
2013
|
0.76
|
|
190
|
Genes, cancer risks, and clinical outcomes.
|
N Engl J Med
|
2007
|
0.76
|
|
191
|
Apportioning causes, targeting populations and predicting risks: population attributable fractions.
|
Eur J Epidemiol
|
2003
|
0.75
|
|
192
|
Correction: vitamin d metabolic pathway genes and pancreatic cancer risk.
|
PLoS One
|
2015
|
0.75
|
|
193
|
Occupation and multiple myeloma: an occupation and industry analysis.
|
Am J Ind Med
|
2010
|
0.75
|
|
194
|
Studies of genes and cancer survival: pieces of the puzzle.
|
J Natl Cancer Inst
|
2007
|
0.75
|
|
195
|
Reducing ovarian cancer death rates through screening.
|
Cancer
|
2010
|
0.75
|
|
196
|
Household endotoxin levels and the risk of non-Hodgkin lymphoma.
|
Cancer Causes Control
|
2013
|
0.75
|
|
197
|
Improving uptake of cancer screening in women.
|
J Womens Health (Larchmt)
|
2007
|
0.75
|
|
198
|
Hobbies with solvent exposure and risk of non-Hodgkin lymphoma.
|
Cancer Causes Control
|
2007
|
0.75
|
|
199
|
Evolving strategies in epidemiologic research on radiation and cancer.
|
Radiat Res
|
2011
|
0.75
|
|
200
|
Chromosomal aberrations in peripheral blood lymphocytes and risk for non-Hodgkin lymphoma.
|
J Natl Cancer Inst Monogr
|
2008
|
0.75
|